Cipla Ltd acquired a 20% stake in Bengaluru-based iCaltech Innovations for ₹5 crore through optionally convertible preference shares and an equity share. This deal strengthens Cipla's presence in respiratory care and diagnostics, providing 20% voting rights in iCaltech, an ISO 13485-certified medical device maker, which reported ₹6.7 crore in revenue for fiscal 2025.
Learn More
Ad
Ad